International Journal of Endocrinology and Metabolism
Research Institute for Endocrine Sciences
OpenCitations
Works that cite this article, indexed by OpenCitations.
Role of epicardial adipose tissue in heart failure with preserved ejection fraction: An emerging molecular mechanism and therapeutic potential
Obesity Reviews 26(7) (2025)
Zhongwen Qi; Dan Wu; Zhipeng Yan; Qing Wang; Yiming Li; Junnan Zhao; Fengqin Xu
The efficacy and safety of oral semaglutide for glycaemic management in adults with type 2 diabetes compared to subcutaneous semaglutide, placebo, and other GLP-1 RA comparators: A systematic review and network meta-analysis
Contemporary Clinical Trials Communications 28 (2022)
Yousef Alhindi; Amanda Avery
Comparative evaluation of biphasic insulin with metformin and triple oral hypoglycemic agents (OHA) in type 2 diabetes patients
Saudi Pharmaceutical Journal 28(2) (2020)
Sirajudeen Shaik Alavudeen; Moteb Khobrani; C.K. Dhanapal; Javid Iqbal Mir; Sultan Mohammed Alshahrani; Noohu Abdullah Khan; Abdulaziz Alhossan
Comparing dual oral agents plus insulin vs. Triple oral agents in uncontrolled type II diabetes: A pilot study
PLOS ONE 19(11) (2024)
Nadia Gul; Inayat Ur Rehman; Yasar shah; Arbab Muhammad Ali; Zahid Ali; Omer Shehzad; Khang Wen Goh; Long Chiau Ming; Amal K. Suleiman
Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach
International Journal of Diabetes in Developing Countries 43(6) (2023)
Ashok Kumar Das; Banshi Saboo; Rajeev Chawla; S. R. Aravind; Rajesh Rajput; Awadhesh K. Singh; J. J. Mukherjee; Ashok Jhingan; Parag Shah; Vaishali Deshmukh; Shailaja Kale; Shalini Jaggi; G. R. Sridhar; Rajnish Dhediya; Kumar Gaurav
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
The Lancet Diabetes & Endocrinology 7(7) (2019)
Ofri Mosenzon; Thalia Marie Blicher; Signe Rosenlund; Jan W Eriksson; Simon Heller; Ole Holm Hels; Richard Pratley; Thozhukat Sathyapalan; Cyrus Desouza; R Abramof; D Alpenidze; S Aronoff; K Astamirova; B Barker; G Bedel; L Belousova; M Benson; I Beshay; W Biggs; K Blaze; P Bogdanski; R Busch; S Chaidarun; S Chandran; A Chang; S Chilka; A Cleland; L Connery; G Cornett; B Delgado; C Desouza; T Donner; K Eliasson; J Eriksson; S Folkerth; K Forshaw; H A Frandsen; E Frolova; W Gandy; G Gatipon; A Golovach; L Gonzalez-Orozco; J Gumprecht; E Haddad; T K Hansen; T Hart; S Hasan; B Hella; S Heller; M Hellgren; M Hewitt; S Hietaniemi; M Hitz; P Houser; R Huntley; R Jackson; P E Jakobsen; A Kapoor; L Kargina; E Kazakova; K Khan; E Klein; H Knoble; N Krasnopeeva (Kabachkova); A Krzeminski; M Kunitsyna; J Lawhead; K Levin; P Levin; L Lewy-Alterbaum; S Lindmark; R Lindsay; A Luts; T Lysenko; S Madsbad; T Maxwell; C Mbogua; J Mcknight; K Metsärinne; T Milovanova; E Morawski; O Mosenzon; D Nabriski; H Nguyen; P Nicol; S Nieminen; A Nikkola; P Norwood; P O'Donnell; A Odugbesan; J Parker; Y Pergaeva; A Peskov; S Plevin; J Pouzar; R Pratley; J Reed; P Rossing; T Sathyapalan; M Sergeeva-Kondrachenko; Z Shaikh; M Shamkhalova; N Shehadeh; Y Shlesinger; R Silver; B Snyder; J Soufer; J Strand; S Sulosaari; A Tirosh; H Traylor; N Uhlenius; G Vagapova; M Yanovskaya; L Zarutskaya; E Zhdanova
Effect of dapagliflozin on 24-hour glycemic variables in Japanese patients with type 2 diabetes mellitus receiving basal insulin supported oral therapy (DBOT): a multicenter, randomized, open-label, parallel-group study
BMJ Open Diabetes Research & Care 11(2) (2023)
Akihiro Kudo; Noritaka Machii; Toshio Ono; Haruka Saito; Yoshito Oshiro; Ryu Takahashi; Koichi Oshiro; Yoshinobu Taneda; Moritake Higa; Ken Nakachi; Shusuke Yagi; Hiroaki Masuzaki; Masataka Sata; Michio Shimabukuro
Glycemic control in newly insulin-initiated patients with type 2 diabetes mellitus: A retrospective follow-up study at a university hospital in Ethiopia
PLOS ONE 17(5) (2022)
Ashenafi Kibret Sendekie; Achamyeleh Birhanu Teshale; Yonas Getaye Tefera
A treatment-based algorithm for identification of diabetes type in the National Health and Nutrition Examination Survey
Cardiovascular Endocrinology & Metabolism 9(1) (2020)
Mitra Mosslemi; Hannah L. Park; Christine E. McLaren; Nathan D. Wong
Hypoglycemic Effect of Calendula arvensis Flowers is Mediated by Digestive Enzyme Inhibition
Current Bioactive Compounds 16(5) (2020)
Abdul-Malik Abudunia; Ilias Marmouzi; Mourad Kharbach; Meryem El Jemli; Karima Sayah; Abdelhakim Bouyahya; Ali Al-kaf; Ali Alyahawi; M’Hammed Ansar; Abdelaziz Bouklouze; My El Abbes Faouzi; Azeddine Ibrahimi
Synergistic Behavior of Phytophenolics with Antidiabetic Drugs
Role of Phenolic Phytochemicals in Diabetes Management (2019)
Muddasarul Hoda; Shanmugam Hemaiswarya; Mukesh Doble
Anestesia y diabetes en el perioperatorio
Anales Médicos de la Asociación Médica del Centro Médico ABC 66(3) (2021)
Angélica Yanine López Ramírez; Norma Elizabeth Carrillo Molina; Jaime Pablo Antonio Ortega García
SGLT2 Inhibition for Cardiovascular Diseases, Chronic Kidney Disease, and NAFLD
Endocrinology 162(12) (2021)
Moein Ala
Drugs That Ameliorate Epicardial Adipose Tissue Inflammation May Have Discordant Effects in Heart Failure With a Preserved Ejection Fraction as Compared With a Reduced Ejection Fraction
Journal of Cardiac Failure 25(12) (2019)
Milton Packer
Hibiscus sabdariffa in Diabetes Prevention and Treatment—Does It Work? An Evidence-Based Review
Foods 11(14) (2022)
Daniel Jamrozik; Weronika Borymska; Ilona Kaczmarczyk-Żebrowska
Rapid detection of insulin by immune-enrichment with silicon-nanoparticle-assisted MALDI-TOF MS
Analytical Biochemistry 577 (2019)
Yichao Wang; Xinwei Han; Zhaoyun Li; Jiaogui Xie
Treatment intensification in type 2 diabetes management after the failure of two oral hypoglycemic agents: A non‐interventional comparative study
International Journal of Clinical Practice 75(3) (2020)
Sirajudeen Shaik Alavudeen; Sultan M. Alshahrani; Easwaran Vigneshwaran; Noohu Abdulla Khan; Javid I. Mir; Abubakr T. M. Hussein
Les inhibiteurs des SGLT2 : traitement anti diabétiques et/ou de la prévention cardiovasculaire et/ou protection rénale ? Place au débat
Archives of Cardiovascular Diseases Supplements 11 (2019)
M. Krempf
Human Insulin Versus Insulin Analogues: A True Companion Forgotten
International Journal of Endocrinology and Metabolism 17(4) (2019)
Hengameh Abdi
Real-world clinical outcomes and costs in type 2 diabetes mellitus patients after initiation of insulin therapy: A German claims data analysis
Diabetes Research and Clinical Practice 174 (2021)
Maximilian Gabler; Nils Picker; Silke Geier; Johannes Foersch; Jens Aberle; Stephan Martin; Matthias Riedl; Thomas Wilke
Insulin Fact Sheet in Type 1 and 2 Diabetes Mellitus and Trends of Antidiabetic Medication Use in Insulin Users with Type 2 Diabetes Mellitus: 2002 to 2019
Diabetes & Metabolism Journal 47(2) (2023)
Jiyun Park; Gyuri Kim; Bong-Sung Kim; Kyung-Do Han; So Yoon Kwon; So Hee Park; You-Bin Lee; Sang-Man Jin; Jae Hyeon Kim